Fields include health research across life stages, from pediatrics to health aging and resilience
The University of Liverpool and McMaster University have announced an institutional strategic partnership to provide £300,000 in seed funding to nine selected projects to support the development of collaborations in key areas of research.
Research areas include health research across life stages from pediatrics to healthy aging and resilience, social sciences, humanities, and the development of port-related activities.
The selected projects were announced by Mr McMaster at a celebratory event attended by representatives from the University of Liverpool.
The three selected health research projects include discovering innovative antibiotics to combat invasive Salmonella in Africa, designing perfusable vascular organoids to study aging and chronic diseases, and using machine learning techniques focused on the development of a pharmacogenetic polygenic risk score.
McMaster President David Farrar commented: “We are proud to partner with the University of Liverpool to fund cutting-edge collaborative research and foster knowledge exchange between students and faculty.
“The recipients of this first round of funding include a diverse range of experts who are driving knowledge creation and research that supports health and well-being in Canada, the UK and beyond.”
This new funding is the latest in a series of collaborative initiatives between McMaster and the University of Liverpool aimed at furthering the University’s mission to accelerate impact in research and education.
In June 2022, McMaster and the University of Liverpool entered into a partnership to advance pandemic preparedness research and training opportunities at both institutions.
Ferrer explained that the two universities will address “opportunities to accelerate vaccine and antibiotic development” while addressing “challenges related to infrastructure, PPE, manufacturing, public policy, and the spread of misinformation.” .
at the University of Liverpool in March earlier this year. announced It will lead a £125 million relativistic ultrafast electron diffraction and imaging facility to drive scientific discovery and technological progress.
Most recently, in April, Mr. McMaster partnered In collaboration with Biomedical Engineering and Imaging Sciences at King’s College London, we support the discovery and development of new health interventions for nuclear medicine research and education.
